Compounds 6 and 16, which showed antiproliferative activity against a panel of cancer cell lines with IC50 values in the low μM range, were tested as tubulin polymerization inhibitors (similarly to TUB015) and as STAT3 inhibitors, using niclosamide as a reference compound. This evidence concerns the gene STAT3 and cancer.